Previous Page  12 / 32 Next Page
Information
Show Menu
Previous Page 12 / 32 Next Page
Page Background

Page 38

Volume 08

Clinical Pharmacology & Biopharmaceutics

ISSN: 2167-065X

Pharmacology 2019

World Heart Congress 2019

August 19-20, 2019

JOINT EVENT

conferenceseries

.com

August 19-20, 2019 Vienna, Austria

&

7

th

World Heart Congress

24

th

World Congress on

Pharmacology

Orthosteric- versus allosteric-dependent activation of the GABAA receptor requires numerically distinct

subunit level rearrangements

Jahanshah Amin

and

Meena S. Subbarayan

University of South Florida, USA

A

nesthetic molecules act on synaptic transmission via the allosteric modulation of ligand-gated chloride channels,

such as hetero-oligomeric α1β2γ2 GABAA receptors. To elucidate the overall activation paradigm via allosteric

versus orthosteric sites, we used highly homologous, but homooligomeric, ρ1 receptors that are contrastingly

insensitive to anesthetics and respond partially to several full GABA α1β2γ2 receptor agonists. Here, we co-expressed

varying ratios of RNAs encoding the wild-type and the mutated ρ1 subunits, which are anesthetic-sensitive and

respond with full efficacy to partial GABA agonists, to generate distinct ensembles of receptors containing five, four,

three, two, one, or zero mutated subunits. Using these experiments, we then demonstrate that, in the pentamer,

three anesthetic-sensitive ρ1 subunits are needed to impart full efficacy to the partial GABA agonists. By contrast,

five anesthetic-sensitive subunits are required for direct activation by anesthetics alone, and only one anesthetic-

sensitive subunit is sufficient to confer the anesthetic-dependent potentiation to the GABA current. In conclusion,

our data indicate that GABA and anesthetics holistically activate the GABAA ρ1 receptor through distinct subunit

level rearrangements and suggest that in contrast to the global impact of GABA via orthosteric sites, the force of

anesthetics through allosteric sites may not propagate to the neighboring subunits and, thus, may have only a local

and limited effect on the ρ1 GABAA receptor model system.

Recent Publications:

1. Walters RJ, Hadley SH, Morris KDW, and Amin J: Benzodiazepines act upon GABA

A

receptors via two distinct

and separable mechanisms. (2000) Nature Neuroscience; 3(12): 1274-1281.

2. W, Hadley SH, Lüddens H, Amin J: Ketamine, But Not Phencyclidine, SelectivelyModulates Cerebellar GABA

A

Receptors Containing

α

6

and

δ

Subunits. (2008) Journal of Neuroscience 28(20): 5383-5393.

3. Morris KW and Amin J: Insight into the mechanism of action of neuroactive steroids. (2004) Mol Pharmacol;

66:56-69.

4. Hadley SH & Amin J: Rat

α

6

β

2

δ

GABAA receptors exhibit two distinct and separable agonist affinities. (2007)

Journal of Physiology 581.3:1001-1018.

5. Amin J, Subbarayan MS. Orthosteric-versus allosteric-dependent activation of the GABAA receptor requires

numerically distinct subunit level rearrangements (2017). Scientific Reports 7 (1), 7770, 1-16.

Biography

J Amin laboratory has a primary interest in GABAA and NMDA receptor-channels. We have studied the structure/function relationship of subtypes of GABAA

receptors to enhance our understanding of the molecular mechanism of action of sedative/hypnotic drugs. By co-expression of wild-type with anesthetic-

sensitive subunits of GABAA receptors, we have determined the minimal number of subunits required for orthosteric- versus allosteric-dependent activation of

GABAA receptor channels. The laboratory is also focused on drug discovery with particular interest in ketamine. In the last several years, we have synthesized

a number of ketamine analogues and characterized their molecular actions on the NMDA and GABAA receptors. One oxime analogues of ketamine has shown

great promise in terms of molecular signature on NMDA and GABAA receptors and in an animal model test for antidepressants.

Jahanshah Amin et al., Clin Pharmacol Biopharm, Volume 08